Treatment of the chronic hepatitis B virus carrier state
- 31 May 1988
- journal article
- review article
- Published by Elsevier in Journal of Infection
- Vol. 16 (3) , 221-229
- https://doi.org/10.1016/s0163-4453(88)97508-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult lifeHepatology, 1986
- Homology between HBV‐DNA and a sequence regulating the interferon‐induced antiviral system: Possible mechanism of persistent infectionJournal of Medical Virology, 1986
- HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection†Hepatology, 1986
- A Randomized Study of the Effects of Adenine Arabinoside 5′–Monophosphate (Short or Long Courses) and Lymphoblastoid Interferon on Hepatitis B Virus ReplicationHepatology, 1985
- Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.Gut, 1985
- Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infectionJournal of Medical Virology, 1985
- Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver diseaseJournal of Hepatology, 1985
- The Spectrum of Immunologic Abnormalities and Clinical Findings in Homosexually Active MenThe Journal of Infectious Diseases, 1984
- Acyclovir in hepatitis B antigen—positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administrationJournal of Antimicrobial Chemotherapy, 1983
- CELLULAR IMMUNITY AND HEPATITIS-ASSOCIATED, AUSTRALIA ANTIGEN LIVER DISEASEThe Lancet, 1972